Help | RSS Feed

PharmaCyte Biotech, Inc. (OTCMKT:PMCB) Seasonal Chart

PharmaCyte Biotech, Inc. (OTCMKT:PMCB) Seasonality

PMCB Relative to the S&P 500
PMCB Relative to the S&P 500

PMCB Relative to the Sector
PMCB Relative to the Sector

Monthly Seasonal PharmaCyte Biotech, Inc. (OTCMKT:PMCB)

Seasonal Chart Analysis

Analysis of the PharmaCyte Biotech, Inc. (OTCMKT:PMCB) seasonal charts above shows that a Buy Date of December 28 and a Sell Date of April 18 has resulted in a geometric average return of 25.61% above the benchmark rate of the S&P 500 Total Return Index over the past 14 years. This seasonal timeframe has shown positive results compared to the benchmark in 10 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 14 years by an average of 46.26% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

PharmaCyte Biotech Inc is clinical stage biotechnology company. It is
engaged in developing and preparing commercialize treatments for cancer and
diabetes based on proprietary cellulose-based live cell encapsulation
technology known as Cell-in-a-Box?.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Sponsored By...
Seasonal Advantage Portfolio by CastleMoore